Tonix Pharmaceuticals was founded in 2010 to develop and bring to market a drug for fibromyalgia. | Tonix Pharmaceuticals was ...

Following decades of limited treatment options, people living with fibromyalgia will soon have access to a novel therapy ...

This approval brings the total to 4 of medications approved to treat fibromyalgia; in addition to cyclobenzaprine HCl ...

(HealthDay News) — The U.S. Food and Drug Administration has approved Tonmya (cyclobenzaprine hydrochloride) sublingual tablets for the treatment of fibromyalgia in adults. The approval is the first ...

Sublingual cyclobenzaprine (Tonmya), a nonopioid treatment for adults with fibromyalgia, targets nonrestorative sleep, a root ...

Tonmya is the first new fibromyalgia treatment approved by the FDA in more than 15 years, providing symptom relief for at ...

Tonix's Tonmya received FDA approval, marking the first new fibromyalgia therapy in 15 years and driving a post-market stock ...

TONMYA's approval is expected to be a key driver of the fibromyalgia treatment market growth, given its first-in-class status ...

Tonix Pharmaceuticals drew heavy retail chatter on Tuesday ahead of an expected U.S. Food and Drug Administration decision on its experimental fibromyalgia treatment TNX-102 SL, due Friday. If ...

Michelle Drerup, PsyD, discusses patients' complex & challenging management of fibromyalgia and sleep disorders.

Fibromyalgia is a complex and often misunderstood condition. For years, it was dismissed as a psychological issue or even a ...